Potential of combined simvastatin and metformin as a low-toxicity therapy alternative to docetaxel for preserving redox homeostasis in triple-negative breast cancer

Medical Hypotheses · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles